Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)

Clinical trial NCT04595747 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04595747
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Gastrointestinal Stromal Tumor Locally Advanced Sarcoma Metastatic Gastrointestinal Stromal Tumor Metastatic Sarcoma Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8

Start date: 2021-05-03
Primary completion: 2027-07-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.